These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28529511)

  • 1. Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.
    Hamze M; Meunier S; Karle A; Gdoura A; Goudet A; Szely N; Pallardy M; Carbonnel F; Spindeldreher S; Mariette X; Miceli-Richard C; Maillère B
    Front Immunol; 2017; 8():500. PubMed ID: 28529511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.
    Karle A; Spindeldreher S; Kolbinger F
    MAbs; 2016; 8(3):536-50. PubMed ID: 26817498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay.
    Schultz HS; Reedtz-Runge SL; Bäckström BT; Lamberth K; Pedersen CR; Kvarnhammar AM;
    PLoS One; 2017; 12(5):e0178544. PubMed ID: 28562666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.
    Mandic M; Almunia C; Vicel S; Gillet D; Janjic B; Coval K; Maillere B; Kirkwood JM; Zarour HM
    Cancer Res; 2003 Oct; 63(19):6506-15. PubMed ID: 14559844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
    Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
    Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab aggregates produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response.
    Nabhan M; Meunier S; Le-Minh V; Robin B; de Bourayne M; Smadja C; Maillère B; Pallardy M; Turbica I
    Eur J Pharm Sci; 2024 Jan; 192():106670. PubMed ID: 38070782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R.
    Sirven P; Castelli FA; Probst A; Szely N; Maillere B
    Mol Immunol; 2009 Apr; 46(7):1481-7. PubMed ID: 19193441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction.
    Barra C; Ackaert C; Reynisson B; Schockaert J; Jessen LE; Watson M; Jang A; Comtois-Marotte S; Goulet JP; Pattijn S; Paramithiotis E; Nielsen M
    Front Immunol; 2020; 11():1304. PubMed ID: 32655572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.
    Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
    Mustafa AS
    Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors.
    Delluc S; Ravot G; Maillere B
    FASEB J; 2011 Jun; 25(6):2040-8. PubMed ID: 21368101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.
    Olive M; Eisenlohr L; Flomenberg N; Hsu S; Flomenberg P
    Hum Gene Ther; 2002 Jul; 13(10):1167-78. PubMed ID: 12133270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors.
    Castelli FA; Szely N; Olivain A; Casartelli N; Grygar C; Schneider A; Besse A; Levy Y; Schwartz O; Maillère B
    J Immunol; 2013 Jun; 190(11):5757-63. PubMed ID: 23636059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors.
    Chevaleyre C; Benhamouda N; Favry E; Fabre E; Mhoumadi A; Nozach H; Marcon E; Cosler G; Vinatier E; Oudard S; Hans S; Le Pimpec-Barthes F; Bats AS; Castelli FA; Tartour E; Maillère B
    J Immunol; 2015 Aug; 195(4):1891-901. PubMed ID: 26136431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.